Prostate-specific antigen and prostate cancer mortality: A systematic review

American Journal of Preventive Medicine

Volumn 45, Issue 3, 2013, Pages 318-326

  Wallner, Lauren P ^a   Jacobsen, Steven J ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER MORTALITY; CANCER SCREENING; DIFFERENTIAL DIAGNOSIS; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; MALE; PROSTATE CANCER; REVIEW; SYSTEMATIC REVIEW;

CASE-CONTROL STUDIES; CLINICAL TRIALS AS TOPIC; HUMANS; MALE; MASS SCREENING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SELECTION BIAS;

EID: 84883037091     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2013.04.015     Document Type: Article

References (22)

1. L.E. Ross, Z. Berkowitz, and D.U. Ekwueme Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey Cancer Epidemiol Biomarkers Prev 17 3 2008 636 644
2. S.M. Prasad, M.W. Drazer, D. Huo, J.C. Hu, and S.E. Eggener 2008 U.S. Preventive Services Task Force recommendations and prostate cancer screening rates JAMA 307 16 2012 1692 1694
3. G.L. Andriole, E.D. Crawford, and R.L. Grubb Mortality results from a randomized prostate-cancer screening trial N Eng J Med 360 13 2009 1310 1319
4. F.H. Schroder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Eng J Med 360 13 2009 1320 1328
5. R. Chou, J.M. Croswell, and T. Dana Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 155 11 2011 762 771
6. F.H. Schroder, and M.J. Roobol ERSPC and PLCO prostate cancer screening studies: what are the differences? Eur Urol 58 1 2010 46 52
7. M.J. Friedrich Debate continues on use of PSA testing for early detection of prostate cancer JAMA 305 22 2011 2273 2275
8. D.C. Miller, and B.K. Hollenbeck Missing the mark on prostate-specific antigen screening JAMA 306 24 2011 2719 2720
9. N.S. Weiss Application of the case-control method in the evaluation of screening Epidemiol Rev 16 1 1994 102 108
10. IOM Finding what works in health care: standards for systematic reviews 2011 National Academy of Sciences Washington DC
11. S. Weinmann, K. Richert-Boe, A.G. Glass, and N.S. Weiss Prostate cancer screening and mortality: a case-control study (U.S.) Cancer Causes Control 15 2 2004 133 138
12. S. Weinmann, K.E. Richert-Boe, and S.K. Van Den Eeden Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality: a case-control study Epidemiology 16 3 2005 367 376
13. J. Concato, C.K. Wells, and R.I. Horwitz The effectiveness of screening for prostate cancer: a nested case-control study Arch Intern Med 166 1 2006 38 43
14. E.J. Bergstralh, R.O. Roberts, S.A. Farmer, J.M. Slezak, M.M. Lieber, and S.J. Jacobsen Population-based case-control study of PSA and DRE screening on prostate cancer mortality Urology 70 5 2007 936 941
15. I. Agalliu, N.S. Weiss, D.W. Lin, and J.L. Stanford Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men Cancer Causes Control 18 9 2007 931 937
16. J.A. Kopec, V. Goel, and P.S. Bunting Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control study J Urol 174 2 2005 495 499 discussion 499
17. S.W. Marcella, G.G. Rhoads, J.L. Carson, F. Merlino, and H. Wilcox Prostate-specific antigen screening and mortality from prostate cancer J Gen Intern Med 23 3 2008 248 253
18. N.S. Weiss Analysis of case-control studies of the efficacy of screening for cancer: how should we deal with tests done in persons with symptoms? Am J Epidemiol 147 12 1998 1099 1102
19. K.A. Cronin, D.L. Weed, R.J. Connor, and P.C. Prorok Case-control studies of cancer screening: theory and practice J Natl Cancer Inst 90 7 1998 498 504
20. T.R. Church A novel form of ascertainment bias in case-control studies of cancer screening J Clin Epidemiol 52 9 1999 837 847
21. J.V. Selby, G.D. Friedman, C.P. Quesenberry, and N.S. Weiss Ascertainment bias in case-control studies of cancer screening J Clin Epidemiol 54 2 2001 215 216
22. R.D. Etzioni, and N.S. Weiss Analysis of case-control studies of screening: impact of misspecifying the duration of detectable preclinical pathologic changes Am J Epidemiol 148 3 1998 292 297